The Business Times
business-time-50
MIND THE GAP

Integrated Shield riders: Fresh focus on cancer drug cover, brace for premium hikes

IP riders now have additional cancer drug benefits far more than the base plans, raising the question of whether current premiums are sustainable

google-preferred-sourceAdd BT as a preferred source
Genevieve Cua

Genevieve Cua

Published Mon, Apr 17, 2023 · 06:00 AM
    • Escalating costs of cancer drugs prompted the creation of a cancer drug list by the health ministry last year, in efforts to rein in costs. Private insurers under the Integrated Shield scheme have to comply with the list this year.
    • Escalating costs of cancer drugs prompted the creation of a cancer drug list by the health ministry last year, in efforts to rein in costs. Private insurers under the Integrated Shield scheme have to comply with the list this year. The Straits Times

    RIDERS to supplement private Integrated Shield Plans (IPs) are set to take on new significance for policyholders, particularly if you are concerned about the extent of cancer drug coverage.

    The big question is – are today’s rider premiums sustainable given the riders’ enlarged role in outpatient cancer cover?

    Insurers in the IP scheme recently rolled out their base IP plans and riders, with reference to the caps for cancer drug coverage, in line with the cancer drug list (CDL) issued by the health ministry last year.

    Mind the GapSpotlight

    TRENDING NOW

    Eugene Lai (left) says that he was sharing a view with Tan Chian Khong that the board needed a refresh and that it was not an explicit direction to resign.

    CSE Global independent director quits after clashes with chairman Eugene Lai over board refresh

    Siranudh Scott had caused an internet sensation with a video accusing his brother of allegedly abusing him during his childhood years.

    ‘I felt like dying’: Thai Singha beer scion speaks up after disclosure of alleged sexual abuse

    In the last round of bidding, the premium for Category B was S$980 more than that for Category A.

    Cat A COE rate exceeds Cat B for third time in 4 months; premiums largely down

    Some industry watchers wonder if Orchard Road can hold its own next to competing retail destinations, both global and local.

    What’s wrong with Orchard Road? Experts weigh in on the street’s cachet and its future

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More